Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
Del Giudice, Ilaria; Chiaretti, Sabina; Santangelo, Simona; Tavolaro, Simona; Peragine, Nadia; Marinelli, Marilisa; Ilari, Caterina; Raponi, Sara; Messina, Monica; Nanni, Mauro; Mauro, Francesca Romana; Piciocchi, Alfonso; Bontempi, Katia; Rossi, Davide; Gaidano, Gianluca; Guarini, Anna; Foà, Robin.
Am J Hematol
; 89(1): 74-82, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24030933
PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL).
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.
Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
Targeting Stereotyped B Cell Receptors from Chronic Lymphocytic Leukemia Patients with Synthetic Antigen Surrogates.
Going through Changes: Surface IgM Levels during CLL Therapy with Ibrutinib.
Sensitizing protective tumor microenvironments to antibody-mediated therapy.
State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia.
The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience.